The Wall Street Journal
In a fresh advance for the burgeoning field of personalized medicine, researchers have developed a blood test based on the DNA of tumors that could help tailor treatment for individual cancer patients.
The report, announced Thursday, represents one of the most tangible
examples yet of how the ability to sequence a person's entire genetic
code could have a direct impact on patient care. There have been a
flurry of reports on new sequencing technology that is yielding
enormous amounts of information about genetics and disease, but that
has yet to deliver much in the way of new treatment strategies... read more